Effects of three peptidase inhibitors, amastatin, captopril and phosphoramidon, on the hydrolysis of [Met5]-enkephalin-Arg6-Phe7 and other opioid peptides
- PMID: 9550299
- DOI: 10.1007/pl00005168
Effects of three peptidase inhibitors, amastatin, captopril and phosphoramidon, on the hydrolysis of [Met5]-enkephalin-Arg6-Phe7 and other opioid peptides
Abstract
The contents of [Met5]-enkephalin-Arg6-Phe7 (met-enk-RF) and its six hydrolysis products: Y, YG, YGG, YGGF, YGGFM, and YGGFMR were estimated after incubating met-enk-RF with either a guinea-pig ileal or striatal membrane fraction for various times at 37 degrees C. After 45 min incubation with either ileal or striatal membranes, met-enk-RF was completely hydrolyzed, yielding Y as the major product. Incubation with either membrane preparation for 60 min in the presence of the aminopeptidase inhibitor amastatin hydrolyzed 90 or 92% of met-enk-RF, respectively, with YGG being the major product. If the dipeptidyl carboxypeptidase I inhibitor captopril is also included in the incubation, met-enk-RF hydrolysis decreases by about half for both membranes, with YGG remaining the major product. Inclusion of three peptidase inhibitors, amastatin, captopril, and phosphoramidon (inhibition of endopeptidase-24.11) further reduced met-enk-hydrolysis, with 87% or more remaining intact. This shows that met-enk-RF was mainly hydrolyzed by three enzymes, amastatin-sensitive aminopeptidase, captopril-sensitive dipeptidyl carboxypeptidase I and phosphoramidon-sensitive endopeptidase-24.11, in both ileal and striatal membranes. Additionally, estimations of [Leu5]-enkephalin (leu-enk), alpha- and beta-neoendorphins (alpha- and beta-neoends), and dynorphin B (dyn B) contents after incubating the individual peptides with striatal membrane for 60 min in the presence of the three peptidase inhibitors showed that 98, 32, 5, and 23%, respectively, remained intact. Our previous studies together with the data obtained here show that one group of endogenous opioid peptides: met-enk, leu-enk, met-enk-RF, met-enk-RGL, and dyn A-(1-8) are largely or almost exclusively hydrolyzed by the three enzymes, amastatin-sensitive aminopeptidase, captopril-sensitive dipeptidyl carboxypeptidase I, and phosphoramidon-sensitive endopeptidase-24.11, and indicate that an unidentified fourth enzyme(s) is involved in the hydrolysis of another group of peptides: alpha-neoend, beta-neoend, and dyn B.
Similar articles
-
Almost complete protection from [Met5]-enkephalin-Arg6-Gly7-Leu8 (Met-enk-RGL) hydrolysis in membrane preparations by the combination of amastatin, captopril and phosphoramidon.J Pharmacol Exp Ther. 1997 May;281(2):769-74. J Pharmacol Exp Ther. 1997. PMID: 9152384
-
Protection against dynorphin-(1-8) hydrolysis in membrane preparations by the combination of amastatin, captopril and phosphoramidon.J Pharmacol Exp Ther. 1998 Aug;286(2):863-9. J Pharmacol Exp Ther. 1998. PMID: 9694943
-
Effects of peptidase inhibitors on the [Met5]-enkephalin hydrolysis in ileal and striatal preparations of guinea-pig: almost complete protection of degradation by the combination of amastatin, captopril and thiorphan.Jpn J Pharmacol. 1986 Aug;41(4):437-46. doi: 10.1254/jjp.41.437. Jpn J Pharmacol. 1986. PMID: 3534399
-
[Enkephalin-inactivating enzymes].Nihon Yakurigaku Zasshi. 1993 Apr;101(4):197-207. doi: 10.1254/fpj.101.4_197. Nihon Yakurigaku Zasshi. 1993. PMID: 8390390 Review. Japanese.
-
Enkephalins, brain and immunity: modulation of immune responses by methionine-enkephalin injected into the cerebral cavity.Int J Neurosci. 1992 Nov-Dec;67(1-4):241-70. doi: 10.3109/00207459208994788. Int J Neurosci. 1992. PMID: 1305637 Review.
Cited by
-
Effect of peptidases on the ability of exogenous and endogenous neurokinins to produce neurokinin 1 receptor internalization in the rat spinal cord.Br J Pharmacol. 2003 Dec;140(8):1389-98. doi: 10.1038/sj.bjp.0705578. Epub 2003 Nov 17. Br J Pharmacol. 2003. PMID: 14623771 Free PMC article.
-
Noxious mechanical stimulation evokes the segmental release of opioid peptides that induce mu-opioid receptor internalization in the presence of peptidase inhibitors.Brain Res. 2008 Mar 4;1197:85-93. doi: 10.1016/j.brainres.2007.12.040. Epub 2008 Jan 3. Brain Res. 2008. PMID: 18207137 Free PMC article.
-
Peptidases prevent mu-opioid receptor internalization in dorsal horn neurons by endogenously released opioids.J Neurosci. 2003 Mar 1;23(5):1847-58. doi: 10.1523/JNEUROSCI.23-05-01847.2003. J Neurosci. 2003. PMID: 12629189 Free PMC article.
-
Comparing analgesia and mu-opioid receptor internalization produced by intrathecal enkephalin: requirement for peptidase inhibition.Neuropharmacology. 2007 Oct;53(5):664-76. doi: 10.1016/j.neuropharm.2007.07.010. Epub 2007 Aug 2. Neuropharmacology. 2007. PMID: 17845806 Free PMC article.
-
Prospects for Creation of Cardioprotective and Antiarrhythmic Drugs Based on Opioid Receptor Agonists.Med Res Rev. 2016 Sep;36(5):871-923. doi: 10.1002/med.21395. Epub 2016 May 16. Med Res Rev. 2016. PMID: 27197922 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous